• About Us
    • Corporate Profile
    • Global Footprint
    • Our Key Milestones
  • manufacturing
    • Infrastructure
    • Dosage Forms & Capacities
  • products & services
    • Products
    • Services
    • Join Hands With Naxpar
  • Investor relations
    • Financials
    • Shareholders Information
    • Compliance
    • Disclosure under Regulation 46 & 62 of SEBI (LODR) Regulations, 2015
    • Investor Contact
  • Catalogues
    • Naxpar Specialities
    • Naxpar Generics
  • Contact Us
    • Contact Us
    • Adverse Event Reporting
AnnualReturn

2020-2021
FinancialDownload2020-2021
Draft Form MGT-7 2020-21Download2021-22
Draft Form MGT-7 2021-22Download2022-23
Draft Form MGT-7 2022-23Download
Copyrights Reserved 2008-2023. Naxpar Group